These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17210636)

  • 1. T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6.
    Lu X; Chen J; Sasmono RT; Hsi ED; Sarosiek KA; Tiganis T; Lossos IS
    Mol Cell Biol; 2007 Mar; 27(6):2166-79. PubMed ID: 17210636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas.
    Lu X; Nechushtan H; Ding F; Rosado MF; Singal R; Alizadeh AA; Lossos IS
    Blood; 2005 Apr; 105(7):2924-32. PubMed ID: 15591113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling.
    Lu X; Malumbres R; Shields B; Jiang X; Sarosiek KA; Natkunam Y; Tiganis T; Lossos IS
    Blood; 2008 Nov; 112(10):4098-108. PubMed ID: 18716132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.
    Davis RE; Brown KD; Siebenlist U; Staudt LM
    J Exp Med; 2001 Dec; 194(12):1861-74. PubMed ID: 11748286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4 distinctively modifies responses of germinal centre-like and activated B-cell-like diffuse large B-cell lymphomas to immuno-chemotherapy.
    Sarosiek KA; Nechushtan H; Lu X; Rosenblatt JD; Lossos IS
    Br J Haematol; 2009 Nov; 147(3):308-18. PubMed ID: 19694722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction.
    Haque SJ; Harbor P; Tabrizi M; Yi T; Williams BR
    J Biol Chem; 1998 Dec; 273(51):33893-6. PubMed ID: 9852037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.
    Guiter C; Dusanter-Fourt I; Copie-Bergman C; Boulland ML; Le Gouvello S; Gaulard P; Leroy K; Castellano F
    Blood; 2004 Jul; 104(2):543-9. PubMed ID: 15044251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP.
    Galic S; Hauser C; Kahn BB; Haj FG; Neel BG; Tonks NK; Tiganis T
    Mol Cell Biol; 2005 Jan; 25(2):819-29. PubMed ID: 15632081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3.
    Simoncic PD; Lee-Loy A; Barber DL; Tremblay ML; McGlade CJ
    Curr Biol; 2002 Mar; 12(6):446-53. PubMed ID: 11909529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression and angiotropism in primary CNS lymphoma.
    Rubenstein JL; Fridlyand J; Shen A; Aldape K; Ginzinger D; Batchelor T; Treseler P; Berger M; McDermott M; Prados M; Karch J; Okada C; Hyun W; Parikh S; Haqq C; Shuman M
    Blood; 2006 May; 107(9):3716-23. PubMed ID: 16418334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
    Lenz G; Wright GW; Emre NC; Kohlhammer H; Dave SS; Davis RE; Carty S; Lam LT; Shaffer AL; Xiao W; Powell J; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Campo E; Jaffe ES; Delabie J; Smeland EB; Rimsza LM; Fisher RI; Weisenburger DD; Chan WC; Staudt LM
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13520-5. PubMed ID: 18765795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.
    Iqbal J; Sanger WG; Horsman DE; Rosenwald A; Pickering DL; Dave B; Dave S; Xiao L; Cao K; Zhu Q; Sherman S; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Ott G; Müller-Hermelink HK; Delabie J; Braziel RM; Jaffe ES; Campo E; Lynch JC; Connors JM; Vose JM; Armitage JO; Grogan TM; Staudt LM; Chan WC
    Am J Pathol; 2004 Jul; 165(1):159-66. PubMed ID: 15215171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
    Lossos IS; Levy R; Alizadeh AA
    Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.
    Bea S; Zettl A; Wright G; Salaverria I; Jehn P; Moreno V; Burek C; Ott G; Puig X; Yang L; Lopez-Guillermo A; Chan WC; Greiner TC; Weisenburger DD; Armitage JO; Gascoyne RD; Connors JM; Grogan TM; Braziel R; Fisher RI; Smeland EB; Kvaloy S; Holte H; Delabie J; Simon R; Powell J; Wilson WH; Jaffe ES; Montserrat E; Muller-Hermelink HK; Staudt LM; Campo E; Rosenwald A;
    Blood; 2005 Nov; 106(9):3183-90. PubMed ID: 16046532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenically active MYD88 mutations in human lymphoma.
    Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
    Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase.
    Sangwan V; Paliouras GN; Abella JV; Dubé N; Monast A; Tremblay ML; Park M
    J Biol Chem; 2008 Dec; 283(49):34374-83. PubMed ID: 18819921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma.
    Shaknovich R; Geng H; Johnson NA; Tsikitas L; Cerchietti L; Greally JM; Gascoyne RD; Elemento O; Melnick A
    Blood; 2010 Nov; 116(20):e81-9. PubMed ID: 20610814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.
    Tagawa H; Suguro M; Tsuzuki S; Matsuo K; Karnan S; Ohshima K; Okamoto M; Morishima Y; Nakamura S; Seto M
    Blood; 2005 Sep; 106(5):1770-7. PubMed ID: 15886317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment.
    Benoit A; Abraham MJ; Li S; Kim J; Estrada-Tejedor R; Bakadlag R; Subramaniam N; Makhani K; Guilbert C; Tu R; Salaciak M; Klein KO; Coyle KM; Hilton LK; Santiago R; Dmitrienko S; Assouline S; Morin RD; Del Rincon SV; Johnson NA; Mann KK
    Int J Hematol; 2024 Mar; 119(3):275-290. PubMed ID: 38285120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP.
    Galic S; Klingler-Hoffmann M; Fodero-Tavoletti MT; Puryer MA; Meng TC; Tonks NK; Tiganis T
    Mol Cell Biol; 2003 Mar; 23(6):2096-108. PubMed ID: 12612081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.